Stock Movers Silicon Lab Climbs on Deal; Lilly Sees Surging Sales; Chipotle Falls
Feb 4, 2026
A blockbuster tech takeover sends a chip designer soaring as markets react to a $7.5 billion deal. Big pharma buzz centers on soaring sales forecasts tied to weight-loss drugs and contrasting warnings from a rival. A major fast casual chain warns of flat sales and shrinking foot traffic as promotions and price worries loom.
AI Snips
Chapters
Transcript
Episode notes
TI Takes Big Bet On Silicon Labs
- Texas Instruments will acquire Silicon Labs for about $7.5 billion, valuing the deal at roughly $231 a share.
- The market reacted strongly, sending Silicon Labs up ~50% while TXN slipped about 3% on the news.
Lilly Riding Weight‑Loss Drug Momentum
- Eli Lilly raised its sales forecast, expecting growth up to 27% driven by weight-loss drugs like Mounjaro and Zepbound.
- Strong demand has helped Lilly outpace rivals amid intensifying price competition in the obesity market.
Price Pressure Splits Drug Market Outcomes
- Novo Nordisk warned sales could fall up to 13% this year, highlighting escalating price pressure and generic competition.
- That contrast underscores how pricing dynamics are reshaping the obesity drug market.